Therapeutic effectiveness disorders of depressive spectrum depending on medical intreventions during prehospital period
https://doi.org/10.20538/1682-0363-2009-4(2)-134-137
Abstract
Open clinical comparative assessment of therapy effectiveness of depressive spectrum disorders was carried out. We compared patients who began treatment in special psychiatric department and those who underwent different consultations, investigations and took medication in primary care before hospitalization. This investigation showed high effectiveness of therapy, reduction of depressive symptoms, improving of psychological state and increasing level of social adaptation in patients who didn’t contact with primary care settings.
About the Authors
N. A. Kornetov
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
Ye. V. Shmunk
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
References
1. American Psychiatric Association: Practice Guideline for Major Depressive Disorder in Adults // Am. J. Psychiatry. 1993. 150 (April suppl).
2. Bagby R.M., Ryder A.G., Cristi C. Psychosocial and clinical predictors of response to pharmacotherapy for depression // J. Psychiatry Neurosci. 2002. № 27 (4). Р. 250—257.
3. Coryell W., Endicott J., Winokur G. et al. Characteristics and significance of untreated major depressive disorder // Am. J. Psychiatry. 1995. № 152. P. 1124—1129.
4. Katon W., Lin E., Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness // General Hospital Psychiatry. 2007. № 29 (2). P. 147—155.
5. Katon W., Von Korff M. et al. Adequacy and duration of antidepressant treatment in primary care // Med. Care. 1992. № 30. P. 67—76.
6. Keller M.B. Underrecognition and undertreatment by psychiatrists and other health care professionals (letter) // Arch. Intern. Med. 1990. № 150. P. 946—948.
7. Keller M.B., Klerman G.L., Lavori P.W. et al. Treatment received by depressed patients // JAMA. 1982. № 248. P. 1848—1855.
8. Keller M.B., Lavori P.W., Klerman G.L. et al. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients // Arch. Gen. Psychiatry. 1986. № 43. P. 458—466.
9. Keller M.B., Lavori P.W., Mueller T.I. et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects // Arch. Gen. Psychiatry. 1992. № 49. P. 809—816.
10. Kessler R.C., McGonagle K.A., Zhao S. et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey // Arch. Gen. Psychiatry. 1994. № 51(8). P. 8—19.
11. Patten S.B. An analysis of data from two general health surveys found that increased incidence and duration contributed to elevated prevalence of major depression in persons with chronic medical conditions // J. Clin. Epidemiology. 2005. № 58. Р. 184—189.
12. Regier D.A., Narrow W.E., Rae D.S. et al. The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services // Arch. Gen. Psychiatry. 1993. № 50. P. 85—94.
13. Tylee A., Gandhi P. The importance of somatic symptoms in depression in primary care // Prim. Care. Companion J. Clin. Psychiatry. 2005. № 7(4). Р. 167—76.
14. Weissman M.M., Klerman G.L. The chronic depressive in the community: unrecognized and poorly treated // Compr Psychiatry. 1977. № 13. Р. 523—532.
Review
For citations:
Kornetov N.A., Shmunk Ye.V. Therapeutic effectiveness disorders of depressive spectrum depending on medical intreventions during prehospital period. Bulletin of Siberian Medicine. 2009;8(4(2)):134-136. (In Russ.) https://doi.org/10.20538/1682-0363-2009-4(2)-134-137
Views:
490
Email this article 